{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CBD+matching+Placebo&page=2", "query": { "intervention": "CBD matching Placebo", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 58, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CBD+matching+Placebo&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CBD+matching+Placebo&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-02T11:34:06.867Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05098509", "title": "A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Prader-Willi Syndrome" ], "interventions": [ { "name": "RAD011", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Radius Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "8 Years to 65 Years" }, "enrollment_count": 4, "start_date": "2022-04-13", "completion_date": "2022-10-31", "has_results": true, "last_update_posted_date": "2023-10-19", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 8, "location_summary": "Los Angeles, California • San Diego, California • Iowa City, Iowa + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Brooklyn", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05098509" }, { "nct_id": "NCT04203498", "title": "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis (MS)" ], "interventions": [ { "name": "Nabiximols", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 139, "start_date": "2020-10-01", "completion_date": "2023-02-28", "has_results": true, "last_update_posted_date": "2024-05-08", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Port Charlotte, Florida • Tampa, Florida + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Port Charlotte", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04203498" }, { "nct_id": "NCT05269628", "title": "Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis", "Sleep", "Pain" ], "interventions": [ { "name": "Cannabidiol (CBD)", "type": "DRUG" }, { "name": "Tetrahydrocannabinol (THC)", "type": "DRUG" }, { "name": "Placebo CBD", "type": "DRUG" }, { "name": "Placebo THC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tiffany J. Braley, MD, MS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 166, "start_date": "2022-03-25", "completion_date": "2027-08-30", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05269628" }, { "nct_id": "NCT03670953", "title": "A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease (Disorder)" ], "interventions": [ { "name": "IR CD-LD", "type": "DRUG" }, { "name": "IPX203 ER CD-LD", "type": "DRUG" }, { "name": "Placebo Matching IPX203", "type": "OTHER" }, { "name": "Placebo Matching IR CD-LD", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Impax Laboratories, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 630, "start_date": "2018-11-06", "completion_date": "2021-06-15", "has_results": true, "last_update_posted_date": "2023-02-09", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 56, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Loma Linda, California + 46 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Loma Linda", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03670953" }, { "nct_id": "NCT05285449", "title": "Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Cannabidiol (CBD) powder formulation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Matching Placebo Cannabidiol (CBD) powder formulation", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Christopher Bell", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2022-02-09", "completion_date": "2024-05-31", "has_results": false, "last_update_posted_date": "2024-07-03", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 1, "location_summary": "Fort Collins, Colorado", "locations": [ { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05285449" }, { "nct_id": "NCT03848832", "title": "Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rett Syndrome", "RTT" ], "interventions": [ { "name": "GWP42003-P", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 29, "start_date": "2019-07-29", "completion_date": "2021-01-21", "has_results": true, "last_update_posted_date": "2022-09-02", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 14, "location_summary": "Birmingham, Alabama • San Diego, California • Aurora, Colorado + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03848832" }, { "nct_id": "NCT04103814", "title": "Effect of Topical CBD Cream for Degenerative Hallux Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Hallux Valgus", "Hallux Rigidus" ], "interventions": [ { "name": "magnesium-cannabidiolic acid cream", "type": "DRUG" }, { "name": "Placebo cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2019-10-20", "completion_date": "2023-05-15", "has_results": true, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04103814" }, { "nct_id": "NCT04732169", "title": "Cannabidiol for Treatment Resistant Depression", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Treatment Resistant Depression" ], "interventions": [ { "name": "Active study drug ( oral CBD)", "type": "DRUG" }, { "name": "matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2021-07-01", "completion_date": "2021-07-09", "has_results": false, "last_update_posted_date": "2021-07-19", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04732169" }, { "nct_id": "NCT04971837", "title": "Interaction Between Cannabidiol, Meal Ingestion, and Liver Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Metabolism", "Liver Function", "Pharmacokinetics" ], "interventions": [ { "name": "Cannabidiol (CBD) powder formulation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Cannabidiol (CBD) Oil based tincture formulation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Cannabidiol (CBD) Gum Arabic, maltodextrin base formulation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Cannabidiol (CBD) Gum Arabic, sorbitol base formulation", "type": "DIETARY_SUPPLEMENT" }, { "name": "Cannabidiol (CBD) Isolate in water formulation", "type": "DIETARY_SUPPLEMENT" }, { "name": "CBD matching Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Colorado State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2021-05-20", "completion_date": "2021-12-09", "has_results": true, "last_update_posted_date": "2024-11-15", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 1, "location_summary": "Fort Collins, Colorado", "locations": [ { "city": "Fort Collins", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04971837" }, { "nct_id": "NCT02224560", "title": "Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy", "Lennox Gastaut Syndrome" ], "interventions": [ { "name": "GWP42003-P", "type": "DRUG" }, { "name": "Placebo control", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "2 Years to 55 Years" }, "enrollment_count": 225, "start_date": "2015-06-08", "completion_date": "2016-05-19", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-02T11:34:06.867Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02224560" } ] }